It was reported that the procedure was to treat a lesion in the non-tortuous, 95% stenosed below the bifurcation of the internal carotid artery.A 9.0 x 40 mm xact stent delivery system (sds) was selected for the procedure.The stent implant was successfully deployed with no issues noted.One hour after the completion of the procedure the patient suffered a minor stroke, was treated with medication and was doing fine.In the opinion of the attending physician the procedure did not cause or contribute to the stroke experienced by the patient.No additional information was provided.
|
(b)(4).There was no reported device malfunction and the product was not returned.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Based on the case information and related record review, a conclusive cause for the reported patient effect, and the relationship to the product, if any, cannot be determined.The reported patient effect of cerebrovascular accident, is listed in the xact instructions for use, as a known adverse event associated with the use of this device in native carotid arteries.There is no indication of a product quality issue with respect to design, manufacture or labeling of the device.
|